Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2017-12-22 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于使用部分闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 特一药业集团股份有限公司 regarding the use of part of idle raised funds for cash management. It details the board meeting approval, the amount and purpose of the funds, investment types, risk control measures, and opinions from independent directors, supervisors, and the sponsoring institution. The document does not contain financial statements or detailed financial performance data but is a disclosure about the company's financing fund usage and management decisions. It is not a full financial report, audit report, or earnings release. The document is a regulatory announcement about capital usage and management, fitting best into the category of Capital/Financing Update (CAP). The document length is under 5,000 characters, but it contains substantive information about financing activities, not just a report publication announcement or a certification. Therefore, the correct classification is CAP with high confidence.
2017-12-22 Chinese
关于控股股东追加股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the additional pledge of shares by a controlling shareholder of the company. It details the number of shares pledged, the pledgee, dates, and the impact on control and financial status. There are no financial statements, earnings data, or management discussion of results. The content focuses on share pledge information by a major shareholder, which is a capital structure update but specifically about share pledging by a controlling shareholder. This fits best under Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes involving share pledges.
2017-12-18 Chinese
关于公司部分高级管理人员股份减持计划实施完成的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the completion of a share reduction plan by a senior management member of the company, Liu Guangtao. It details the number of shares reduced, the dates, and compliance with relevant regulations. The content focuses on insider share transactions by a company executive, including specific share quantities, percentages, and trading methods. There is no financial report, earnings data, or other types of filings such as annual reports or management discussions. This fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives.
2017-12-14 Chinese
关于第三届董事会第十九次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board of directors meeting of 特一药业集团股份有限公司. It details the date and manner of the meeting, attendance, and specific decisions made, such as approval of issuing convertible bonds and opening special accounts for raised funds. There is no financial statement or detailed financial data presented, only the board's decisions and voting results. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board. The document length is short (1460 characters), and it is not a report or financial statement itself but a meeting resolution announcement.
2017-12-12 Chinese
公开发行可转换公司债券发行结果公告
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding the issuance results of convertible bonds by 特一药业集团股份有限公司. It details the amount issued, allocation between original shareholders and public investors, subscription and payment status, underwriting details, and contact information for the underwriting institution. The document does not contain financial statements or detailed financial analysis but rather reports on the outcome of a capital raising activity. The length is short (1562 characters), and the content focuses on the issuance and subscription results of convertible bonds, which is a financing activity. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2017-12-11 Chinese
关于控股股东追加股份质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the additional pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the pledgee, dates, and the impact on control and financial status. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about a shareholder's share pledge activity, which fits the category of Major Shareholding Notification (MRQ) as it involves disclosure of significant shareholding changes and pledges by a major shareholder.
2017-12-11 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.